The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma
Author(s) -
Étienne Cavalier,
Adrian Daly,
Daniela Betea,
Pamela Nicoleta Pruteanu-Apetrii,
Pierre Delanaye,
Phil Stubbs,
A.R. Bradwell,
Jean-Paul Chapelle,
Albert Beckers
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-2791
Subject(s) - third generation , medicine , tertiary referral centre , tertiary hyperparathyroidism , urology , parathyroid carcinoma , parathyroid hormone , primary hyperparathyroidism , transplantation , first generation , adenoma , dialysis , gastroenterology , endocrinology , calcium , secondary hyperparathyroidism , telecommunications , computer science , population , environmental health
Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is recognized by third-generation but not by second-generation PTH immunoassays. In normal individuals, the third-generation to second-generation PTH ratio should be less than 1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom